We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$7.79B
AUM Growth
+$1.66B
Cap. Flow
+$1.24B
Cap. Flow %
15.91%
Top 10 Hldgs %
68.56%
Holding
80
New
15
Increased
18
Reduced
10
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 28.44%
2 Utilities 18.49%
3 Energy 7.97%
4 Technology 4.19%
5 Financials 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLN
1
Talen Energy Corp
TLN
$16.7B
$1.23B 15.83%
6,123,500
-5,245,114
-46% -$1.02B
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$1.17B 15.04%
+2,000,000
New +$1.18B
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$83B
$1.12B 14.38%
+5,070,000
New +$1.16B
TEVA icon
4
Teva Pharmaceuticals
TEVA
$41.2B
$375M 4.81%
17,000,000
+994,502
+6% +$18.1M
GLNG icon
5
Golar LNG
GLNG
$5.13B
$326M 4.19%
7,710,211
+1,175,149
+18% +$45.8M
VTRS icon
6
Viatris
VTRS
$18.9B
$251M 3.22%
20,144,365
QDEL icon
7
QuidelOrtho
QDEL
$838M
$247M 3.17%
5,550,000
+1,350,000
+32% +$55.2M
ROIV icon
8
Roivant Sciences
ROIV
$26.2B
$237M 3.04%
20,000,000
-2,400,000
-11% -$28.4M
NFE icon
9
New Fortress Energy
NFE
$101M
$227M 2.91%
+15,000,000
New +$155M
BGC icon
10
BGC Group
BGC
$4.89B
$154M 1.97%
16,976,380
+3,800
+0% +$36.6K
ARQT icon
11
Arcutis Biotherapeutics
ARQT
$3.18B
$153M 1.96%
10,966,672
TAC icon
12
TransAlta
TAC
$3.93B
$108M 1.38%
7,612,663
+1,989,702
+35% +$22.7M
COOP
13
DELISTED
Mr. Cooper
COOP
$103M 1.32%
1,067,680
+31,682
+3% +$3.01M
RNW icon
14
ReNew
RNW
$2.25B
$99.2M 1.27%
14,527,412
+821,310
+6% +$5M
UAL icon
15
United Airlines
UAL
$42.1B
$96.7M 1.24%
995,759
-116,864
-11% -$9.88M
SDGR icon
16
Schrodinger
SDGR
$1.36B
$96.5M 1.24%
5,000,000
+1,314,497
+36% +$25.5M
ADPT icon
17
Adaptive Biotechnologies
ADPT
$3.97B
$87.5M 1.12%
14,600,000
+200,000
+1% +$1.1M
AMRX icon
18
Amneal Pharmaceuticals
AMRX
$5.79B
$84.9M 1.09%
10,721,778
LBTYA icon
19
Liberty Global Class A
LBTYA
$3.6B
$84.2M 1.08%
6,595,439
+1,064,538
+19% +$17.8M
ALIT icon
20
Alight
ALIT
$407M
$80.6M 1.03%
582,334
OPK icon
21
Opko Health
OPK
$1.02B
$71.6M 0.92%
48,706,640
DOLE icon
22
Dole
DOLE
$1.32B
$70.4M 0.9%
5,200,000
+58,612
+1% +$900K
COLL icon
23
Collegium Pharmaceutical
COLL
$956M
$67.3M 0.86%
2,350,000
+1,100,000
+88% +$36.4M
FLR icon
24
Fluor
FLR
$7.96B
$65.3M 0.84%
1,325,000
-1,458,441
-52% -$76.9M
ADEA icon
25
Adeia
ADEA
$3.11B
$64.9M 0.83%
4,640,009

Similar funds

Rubric Capital Management (New York)'s Q4 2024 Portfolio in Review

As of Q4 2024, Rubric Capital Management (New York) held 80 positions worth $7.79B, up 27% from $6.14B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Rubric Capital Management (New York) deployed $1.24B of net new capital in Q4 2024, opening 15 new positions and adding to 18 existing holdings. Its largest new stake was New Fortress Energy: 15,000,000 shares worth $227M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 33% a quarter earlier, followed by Utilities and Energy.

On the sell side, the largest reduction was Talen Energy Corp, an estimated $1.02B trimmed.

  • Rubric Capital Management (New York)'s largest Q4 2024 buy was New Fortress Energy: 15,000,000 shares worth $227M.
  • Rubric Capital Management (New York) added most to QuidelOrtho in Q4 2024, an estimated $55.2M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2024 reduction was Talen Energy Corp, cutting an estimated $1.02B.
  • Rubric Capital Management (New York) fully exited Vistra in Q4 2024, selling an estimated $252M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 69% of its $7.79B portfolio in Q4 2024.
  • Rubric Capital Management (New York) opened 15 new positions and closed 11 in Q4 2024.
  • Rubric Capital Management (New York)'s portfolio value rose 27% quarter-over-quarter to $7.79B.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.